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The ban on the sale of kava pills, imposed in 2002 by some European 
countries, severely compromised the sustainability of the trade in kava 
roots from the Pacifi c. However, the lifting of restrictions in October 2008 
has allowed trade to resume, with “a 2 year road map” drawn up to pur-
sue legal and alternative options for the registration of kava in Europe 
(ikec 2008, 1). The pill form in which kava has been sold in Europe as 
an herbal remedy for anxiety and insomnia was manufactured by German 
and other European pharmaceutical companies using kava root material 
imported from the Pacifi c. Claims that toxic elements in the kavalactones 
(the main chemical components) damaged the health of individuals tak-
ing the pills were met with counterclaims by researchers and those who 
have grown and drunk kava beverages in the Pacifi c for many years with 
very few side effects. The only problematic physical symptoms reported 
by frequent consumers of the beverage were scaly skin and bloodshot eyes 
(Lebot 2006; Ernst 2007). Kava farmers in Vanuatu, Fiji, Pohnpei, and 
elsewhere in the Pacifi c sought assistance to have the ban lifted so that 
they could resume export production (see, eg, Gruenwald and Mueller 
2003; ikec 2008). 
Sustainability of the kava trade is at risk. According to the World 
Commission on Environment and Development, sustainability refers to 
the development needs of current generations that must be met without 
compromising the ability of future generations to meet their own needs 
(Suzuki and Dressel 2002). In their 2002 book, David T Suzuki and Holly 
Dressel stressed the need to protect natural resources from outsiders who 
have no attachment to an area and are primarily interested in ever-higher 
profi ts, as well as to protect local communities from being overwhelmed 
and impoverished by fi nancial and cultural forces working on the global 
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level. They tried “not only to analyze what is happening to our physical 
support systems but also to suggest some areas of our culture that are ripe 
for change” (Suzuki and Dressel 2002, 4–5).
Vociferous opposition to world trade policies that limit the trading 
potential of developing countries has necessitated a rethinking of World 
Bank and International Monetary Fund policies on assistance to those 
nations. Joseph E Stiglitz has argued that trade liberalization policies must 
be concerned with sustainability, not only in a narrow economic sense of 
increased gross domestic product, but also socially, politically, and envi-
ronmentally (2006, 17). Stiglitz underlined the importance of reducing 
the poverty gap between rich and poor nations by setting in place fairer 
trade regimes. Many small nations already encounter diffi culties selling 
their products, thus demonstrating that some aspects of globalization have 
proved detrimental. Restrictions (such as the European kava ban) work 
against development options. Development policies that encourage new 
income sources fall prey to counterclaims for consumer protection, in this 
case, health concerns.
The biodiversity of a plant such as kava is also compromised by phar-
maceutical companies’ demands for a “standardized” product. Some one 
hundred and twenty species or clonal varieties of the plant have been iden-
tifi ed across the islands of Melanesia, Polynesia, and Micronesia. Indeed, 
kava has been grown and selectively developed locally by Pacifi c commu-
nities over a period of three thousand years (Lebot 1995, 2006). Different 
qualities of these cultivars have been selected to meet local cultural and 
environmental needs. Vincent Lebot claimed that the diversity of root vari-
eties in Melanesia, in particular, is unequaled anywhere else on earth (Wal-
ter and Lebot 2007, 4:16). However, when it comes to the commercializa-
tion of the plant, German pharmaceutical companies require a “standard” 
product to meet their particular interests. A replicable supply of kavalac-
tones for the manufacturing process to ensure a healthy, nontoxic prod-
uct is required in order to satisfy quality assessments (Ernst 2007). These 
contrasting demands on the kava plant relate to the underlying question 
of whether sustainability of the kava trade is better focused on expanding 
exports for cultural continuity, or for commercial gain. Restoring kava 
output will contribute to the preservation of cultural heritage, while also 
assisting island economies. Restoring the positive image of kava world-
wide is also an important goal.
The current status of the kava trade is examined here on three fronts: 
customary exchanges of kava roots according to adaptive cultural proto-
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cols; exports of kava for customary usage by migrant communities around 
the Pacifi c rim; and exports of kava to pharmaceutical companies for fur-
ther development as a herbal medicine. The impact of these concerns on 
four Pacifi c communities—Vanuatu, Fiji, Tonga, and Pohnpei—demon-
strates the diversity of scenarios of kava use into the future. I also briefl y 
consider the introduction of kava to Australian Aboriginals as an alter-
native to alcohol and the subsequent ban on the plant by the Australian 
government in 2007.
Sustainability of the kava trade, it is argued, is balanced between sev-
eral alternative outcomes: continuing the access to resources over both 
the short and long term; maintaining the availability of resources for both 
social and economic benefi ts; and insuring that those benefi ts can accrue 
locally, as well as globally. 
Background
The term kava is used for both the plant Piper methysticum and the bever-
age made from the plant. The terms kava and ‘ava (or yaqona in Fiji) refer 
to the bitter taste of the beverage. Over many generations, households in 
the Pacifi c have selectively planted in their gardens the kava plants that 
best suit their tastes and environment. The root of the plant is pounded 
(or chewed, in traditional practice) and water added to produce a bev-
erage that was traditionally drunk, usually by senior men, in ritual cir-
cumstances (for botanical and ethnographic detail, see Lebot, Merlin, and 
Lindstrom 1992; Pollock 1995a). The close association between kava con-
sumption and rituals honoring the ancestral gods is maintained in Vanu-
atu, Fiji, and several Polynesian societies, while more recent secular use 
represents a “democratization of kava” with its usage in kava bars in Van-
uatu, Tonga, and Pohnpei (see Pollock 2008a for discussion of diversity 
across the Pacifi c over time; see McDonald and Jowitt 2000 for Vanuatu). 
But regardless of context, respect for the kava remains paramount among 
Pacifi c Islands users. 
Kava is regarded as a pleasurable social drink, and individuals rarely 
drink it alone. Indeed, it is the soothing, relaxing qualities of the kava bev-
erage that attracted the attention of pharmaceutical manufacturers who 
saw its potential in the 1980s in the rapidly expanding market for herbal 
alternatives to prescription medicines (Singh 2004). The sudden interest 
in the kava plant for medical uses altered perspectives on the plant. Con-
sidered alongside St John’s Wort, gingko, and other herbs being devel-
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oped as herbal remedies, kava products have been classifi ed variously as 
pharmaceuticals (medicinal drugs), nutraceuticals (over-the-counter nutri-
tional supplements), herbal products (see HerbalGram Web site, www.
herbalgram.org), and anxiolytics (drugs prescribed to treat symptoms of 
anxiety) (Pittler and Ernst 2003). Experts from a range of fi elds—includ-
ing toxicologists, clinical pharmacologists, pharmacognosists (who study 
medicines from natural sources), as well as cytobotanists and social sci-
entists—have been drawn to research the plant’s safety with regard to 
human health. All have contributed their assessments regarding the medi-
cal safety of kava, and how the product (in pill form) should be regulated 
(Richardson and Henderson 2007, 418; for further details of the health 
issues associated with kava use, see Pollock forthcoming).
The variety of modes of kava production and usage in the Pacifi c fur-
ther attest to the biodiversity of kava. Environmental conditions, choice of 
planting stock, length of time before harvesting, use of root material (and 
stem in some cases) are all matters of cultural selection (for details, see 
Lebot, Merlin, and Lindstrom 1992; Lebot 1995). Here I consider Vanu-
atu, Fiji, Tonga, and Pohnpei as examples of those variations in terms 
of the sustainability of the kava trade, whether for customary usage, for 
supplying island communities living away from home, or for exporting to 
pharmaceutical companies.
Because it restricted trade development, the 2002 European ban on 
kava root imports elicited expressions of concern from the Pacifi c Islands 
Forum and other agencies on behalf of emerging business ventures in the 
Pacifi c as well as local farmers. The face-off between trade and biodiver-
sity arguments represents a struggle between the interests of farmers from 
developing nations on the one hand and large multinational pharmaceuti-
cal companies on the other; the drug companies see fi nancial incentives 
for themselves while dismissing the need for incentives for others (Stiglitz 
2006, 125). 
The knowledge base that local kava producers have built in the area 
of conservation, breeding, domestication, and development of plant and 
animal genetic resources is being appropriated for short-term economic 
exploitation. Profi teering through the selection of commercially desirable 
products from the genetically diverse storehouses has led to a devaluation 
of life forms (Shiva 1995, 64). Vandana Shiva urged developing nations to 
take stock of their genetic resources in order to conserve them for future 
generations and the long-term benefi t of indigenous peoples. She argued 
that “a schizophrenic approach to diversity”—which adopts a policy of 
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destruction of diversity while supporting a policy of preservation of “set-
asides,” or conservation—not only overrides many years of intellectual 
contribution to environmental development, but also restricts the long-
term future of that environment. The issue regarding the sustainability of 
kava represents in a salient way the confl ict between sustainable develop-
ment and conservation. 
Diversity of Kava in the Pacifi c
Kava is an iconic crop in the Pacifi c (Pollock 2000). Nowhere else has 
it been cultivated so extensively (Lebot 2002). According to archaeolo-
gists and historical linguists (Bellwood 2004; Blench 2005), kava has been 
traded across the Pacifi c for more than 3,000 years. Rootstock carried by 
early Pacifi c voyagers was regenerated by vegetative propagation across 
islands in the central and eastern Pacifi c, eastward from Fiji to Tahiti (it 
reached the Society Islands perhaps six hundred years ago [Brunton 1989, 
28]), then northwest to Pohnpei and Kosrae. It proliferated in Vanuatu, 
though in New Guinea it has a relatively limited distribution and is rarely 
found today (Lebot and Cabalion 1986). In the modern era of gastro-
nomic exploration and molecular biology, we have a fairly full picture of 
the kava plant and its uses (Walter and Lebot 2007). Many publications 
have covered its phytochemistry, production, and processing techniques, 
as well as its ritual uses and the rich world of associated myths (see bibli-
ography in Singh 2004). The “power of kava” as a social beverage, with 
a long tradition in ritual and secular contexts, is the basis for its strong 
identifi cation as a Pacifi c icon (Pollock 1995a).
Signifi cant variations can be noted for four island communities: Vanu-
atu, Fiji, Tonga, and Pohnpei.
Vanuatu
Northern Vanuatu—considered the “homeland” of the domesticated kava 
plant—has the greatest range of variants (Lebot and Cabalion 1986; Wal-
ter and Lebot 2007). Its wild precursor, Piper wichmanii, ranged from 
New Guinea to northern Vanuatu. Lebot has claimed that the antiquity of 
the use of kava in Vanuatu is further indicated by the complexity of folk 
taxonomies for the plant throughout those islands. He recorded the names 
and characteristics of 247 kava cultivars across Vanuatu (Lebot 1997, 97) 
and listed the names of 16 cultivars for Pentecost, and 16 different names 
for Tanna, which refer either to morphological characteristics, a legend, 
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or to the name of the person who developed that cultivar (Lebot 1997, 
99–103). 
Kava bushes were planted on most islands of Vanuatu except for 
Ambrym and South Malekula (Brunton 1989, 19). Farmers selected dif-
ferent varieties for vegetative propagation on their household plots. Sites 
for planting kava today are carefully chosen so that newly planted stems 
are protected from direct sunlight and wind. The plant requires fairly high 
average temperatures (20–35 degrees Celsius), high humidity, and deep, 
well-drained soils; hillsides are particularly well suited. The plant can be 
harvested after three or four years by cutting above the fi rst node. Special-
ized local knowledge has been applied to develop kava plants that produce 
a beverage that suits local tastes while also improving the yield (Lebot and 
Brunton 1985, 82–85). Commercial plantations have been developed over 
the past fi fteen to twenty years.
The brew from some Vanuatu kava rootstock is reputed to yield the 
strongest physiological effect of any Pacifi c varieties (Lebot 2002; Lebot 
and others 1999). Ni-Vanuatu process the drink from the fresh green 
roots, which diverges from practices in other parts of the Pacifi c. They 
also add less water than do people in other Pacifi c societies, thereby pro-
ducing a high concentration of kavalactones. On Tanna, sixteen named 
cultivars indicate locally discriminated features. For example, the right to 
consume one special form, nikawa tipuga, is restricted to certain families 
(Lebot, Merlin, and Lindstrom 1992, 102, 87). Lebot has suggested that 
both variation in soils and cultivar types may contribute to the strength 
of the beverage (2002). Chewing the rootstock (an old practice) releases 
kavalactones in water more readily than pounding or grating, but this is 
rarely done today.
Drinking kava was abandoned by ni-Vanuatu communities for almost 
a hundred years, mainly due to Christian missionaries’ attempts to elimi-
nate competition with other gods (Brunton 1989, 124). However, since 
Vanuatu’s independence in 1980, kava has been revived as a symbol of 
ni-Vanuatu identity (Crowley 1995). Not only was planting encouraged 
as export potential loomed, but the government of the day also promoted 
it as an alternative to alcohol. 
Kava has become a major cash crop for ni-Vanuatu. Three thousand 
hectares have been developed, much of that land in newly extended plan-
tations. In 2000 (two years before the European ban), kava was yielding 
1.25 million vatu per year for the national economy, the largest earnings 
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of the seven major crops Vanuatu produces (Lebot 2002, 6). (The vatu is 
Vanuatu’s currency; in 2002, us$1.00 was the equivalent of 143.50 vatu; 
today us$1.00 is 110.00 vatu.) For farmers today, kava yields 100 vatu 
per kilogram (kg), or 1 billion vatu per annum, and is thus a major source 
of income. In Vanuatu, 5,000 tonnes of kava are sent to Port Vila and 
2,500 tonnes to other centers for use in the kava bars, while 2,500 tonnes 
of fresh root are dried annually for the export market (to yield 500 tonnes 
dry weight) (Lebot 2002, 5). 
Kava is strongly promoted on the Vanuatu Tourism Offi ce Web site 
to appeal to visitors and tourists (vto nd). Drinking kava is emphasized 
as an integral part of the Island experience. The cash return from hotel 
performances, or from subsequent sales to tourists leaving for home, is 
not distinguished from other kava income in Vanuatu. The root is sold in 
its green form for the local market, while the dried product from crushed 
roots is exported from Vanuatu to both Fiji and Europe, according to 
Roxanne Naylor, chief executive offi cer of the Kava Kompani in Port Vila 
(pers comm, 2002). Stems and shavings are also exported, giving rise to 
some criticism of quality control. Several independent producers have 
developed their own product, but the Kava Kompani is the major agent 
for exports from Vanuatu to European pharmaceutical companies, and to 
Fiji. The Kava Kompani, together with Kava Trading Company, have been 
actively engaged in compiling background materials to lobby against the 
ban on behalf of ni-Vanuatu farmers (Naylor, pers comm, 2003; Charles 
Long Wah, pers comm, Oct 2008).
A survey of local usage by Jenny Binihi and Anita Jowitt in 1999 in 
Port Vila (reported in McDonald and Jowitt 2000) found that custom-
ary usage was less than 10 percent of total usage; others drank mainly 
at kava bars. Of the sample surveyed, 44 percent noted that kava was 
“socially  addictive.” The report concludes that “relatively few acute prob-
lems linked to kava use are reported in the Pacifi c,” but recommends sev-
eral steps toward “harm reduction.” The authors observed that changes in 
the social controls over kava use are taking place (McDonald and Jowitt 
2000, 226). 
The Vanuatu economy has much to gain from establishing a stable mar-
ket for this kava. Lebot has suggested that several steps are necessary to 
ensure the sustainability of Vanuatu export sales to international mar-
kets; these include reducing variability between cultivars and cultivation 
sites, using only root material to produce a standardized product, and 
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establishing quality controls. Modes of drying, processing, packaging, and 
transporting kava also contribute to a highly diverse product arriving at 
pharmaceutical companies in Europe (Lebot 2006). Quality control steps 
are vital if a reliable export market is to be reinstated, though they would 
not necessarily eliminate the diversity of kava produced in Vanuatu for the 
local market.
Research scientists such as Lebot lobbied against the European ban by 
contributing to discussions between European pharmaceutical manufac-
turers and the International Kava Executive Council (ikec) deliberations. 
Responding to the United Kingdom’s determination to continue the Euro-
pean Union ban in 2006, Lebot, in liaison with European offi cials, contrib-
uted data on the growing conditions from which the dried product is pro-
duced—data that was vital in the efforts to lift the kava ban in 2008. The 
concern now is to ensure that the kavalactones exported are safe and that 
local producers are willing to work to produce a more marketable product 
(Lebot 2006). Lebot, as well as Port Vila businessman and kava exporter 
Charles Long Wah (pers comm 2008), are marginally optimistic for the 
sustainability of the international trade, after a slow recovery phase.
The kava trade in Vanuatu is highly likely to continue for local use 
in clan settings and in nakamal / kava bars. Overseas communities of ni-
Vanuatu, especially those living in New Caledonia, are ready recipients 
of kava grown in their home islands, for drinking in their nakamal; they 
prefer it to kava from Fiji or elsewhere. But exports to European pharma-
ceutical companies remain at risk until the issues of quality control are 
resolved (ikec 2008).
Fiji
Fiji has become a central player in many aspects of the kava trade. Fijian 
kava, known as yaqona, features prominently at many social occasions 
today, both secular and ritual, though in the past its uses were mainly 
ritual (Ravuvu 1983). 
Just how long the plant has been used in Fiji is still the subject of debate. 
It is likely that cultivars, originating from northern Vanuatu, were trans-
ferred during the spread of Lapita peoples eastward some three thousand 
years ago (Kirch 2000), and later featured in exchanges between Tonga, 
Fiji, and Wallis during the fi fteenth and sixteenth centuries. Along with the 
rootstock, ceremonial uses of the kava root spread widely throughout this 
early Tongan empire (Pollock 1996).
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The plant grows well throughout the two main high islands of Fiji: Viti 
Levu and Vanua Levu. The eastern islands of the Lau group had not been 
surveyed by Lebot by 1992, but historical Tongan connections are likely 
to provide interesting data regarding the cultivation of kava in that area. 
Family (mataqali) kava plots have been noted in early botanical and ethno-
graphic literature, along with descriptions of exchanges, usage, and myths 
(see, eg, Seemann 1862; Quain 1948; Ravuvu 1983). Planting methods 
are similar to those in Vanuatu and Tonga. Lebot recorded the names and 
characteristics of eleven cultivars in the 1980s, but in addition he noted 
many named cultivars that farmers distinguish by the color and shape of 
the plant’s internodes (Lebot, Merlin, and Lindstrom 1992, 92). 
Fijians distinguish several forms of the root. Small lateral roots, termed 
waka, are the most common part of the plant used and sold in urban mar-
kets. Alternatively the dried rootstock, known as lewena, can be used, as 
can the basal portion of the plant’s stems, known as kasa. Each type of 
yaqona has a different price. 
Plantations of yaqona bush that began on a small scale in the 1950s 
have been expanding over the last fi fteen years. Lebot recently estimated 
that some six thousand hectares were devoted to growing the crop, twice 
the area in Vanuatu (2002). Total tonnage increased from 145 tonnes in 
1990 to 1192 tonnes in 1998. The export market that accelerated in the 
1990s encouraged farmers, with government support, to devote more of 
their land to growing the plant in expectation of high returns per hectare 
for a crop that requires minimal care. Yaqona rose from sixth to fourth 
place on the list of viable exports (Murray 2000). “Cultivation of kava 
for sale is a clear example of market infl uenced indigenous development 
based on local technical knowledge and skills, and derived from custom-
ary practices” (Maiava and King 2007, 89). 
Internal marketing also suffered. Warwick Murray’s case study of 
Taveuni growers revealed that they lost much of the fi nal market value of 
their kava crop to a chain of intermediaries (2000). In Vanua Levu where 
kava was replacing coconut plantations, waka roots were selling for more 
than the lewena and kasa. The grower sold waka roots for f$18 per kg, 
which then sold in Suva for f$28–30. (In 2000, f$1.00 was the equivalent 
of us$.50.) Roots may be exported unprocessed to the large pharmaceu-
tical manufacturers, or dried, pounded, and sealed in 500-gram plastic 
packets. The price paid by the European purchaser is highly variable, but 
in 1998 there were reports of kava roots selling for us$80 per kg. Mur-
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ray was pessimistic about the long-term future of yaqona sales from Fiji 
(2000, 367). 
Formerly, though women had a role in the preparation and formal pre-
sentation of kava, it was consumed mainly by Fijian men; however, that 
is changing. Research in western Fiji in the late 1990s found that “grog” 
users drank yaqona to relieve tension and anxiety, relieve insomnia, pro-
mote sociability, and improve urination. The negative effects of scaly skin, 
watery eyes, headache, and so on, occurred only in heavy users, that is, 
those drinking 300 grams or spending f$12 per week or more (Kava 2001, 
117). Shane Aporosa is currently conducting PhD research on the effects 
of kava drinking on work habits in Fiji (pers comm, 2008).
Recent research by Tarisi Vunidilo indicates the importance of wom-
en’s contributions to kava practice in precolonial times, as well as their 
involvement in kava circles today (2006). She reported that her mother on 
Kadavu, used kava selectively and in moderation for medicinal purposes, 
such as for stomach ailments or during pregnancy. Vunidilo’s paper high-
lights the need for further in depth research into not only the role of Pacifi c 
women in preparing the beverage, but also their own selective uses of it.
Fijian yaqona is more readily available in New Zealand than other types 
of kava. Plastic bags containing 500 grams of powdered roots can be pur-
chased for nz$6–10 by Pacifi c Islander communities and by tourists to 
take home as souvenirs. (In November 2008, nz$1.00 was the equivalent 
of approximately us$.58.)
Ratu Josaleka Nawalowalo has been an active contributor to the inter-
national discussions leading to the lifting of the European ban. In 2002, 
the Fiji Kava Council was formed under his chairmanship to coordinate 
the concerns of farmers regarding the loss of revenue due to the ban. 
Today, the Fiji Council provides a channel for farmers to articulate their 
viewpoints in the wider debate about the future viability of trading kava. 
Tonga
Tonga is the Polynesian homeland of kava and, along with Sämoa, has the 
strongest tradition in terms of the maintenance of kava use for ceremonies 
and the recognition of status. The plant was a central feature of the asso-
ciations between Tonga and its early empire in the seventeenth century 
(Pollock 1995b). During the early Tongan maritime empire in the fi fteenth 
and sixteenth centuries, cultivars of kava and many important food crops, 
along with their associated customs, were shared by Tongans voyaging 
far and wide in the central Pacifi c. Fiji, Wallis, Futuna, Rotuma, and Niue 
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all participated in the empire, in which members of the highest strata in 
society were honored by kava rituals (Pollock 1995b, 1996). 
Ceremonial usage and myths associated with kava have been exten-
sively recorded and analyzed (see, eg, Bott 1987; Perminow 1995). Bott 
has suggested that “the kava ceremony is one of a series of ceremonies that 
clarify social principles and social roles” and thus has contributed to the 
maintenance of those principles (1987, 191–201). In the ritual context, 
kava is a male beverage. The highest-ranking person being honored sits 
at the center of the “kava circle” with his dignitaries on either side. With 
regard to “royal kava,” the beverage is served during major events associ-
ated with the Tongan royalty, as witnessed at the 1976 celebrations of the 
twenty-fi fth anniversary of King Täufa‘ähau Tupou IV’s accession to the 
throne. The celebration drew together Tongans who brought contribu-
tions from all reaches of the kingdom (author’s fi eld notes, 1976). The 
royal kava ceremony for the induction of the new king, George Tupou 
V, in August 2008, underscored kava’s continued prominence in Tongan 
ritual in the contemporary period.
As well as functioning as a ritual beverage, kava is used informally. 
Traditionally, both men and women used it medicinally, to relieve urinary 
problems, colds, and headaches; it has also been used to treat impotency 
(Halavatau and Hoponoa 2002). Informal use of kava has increased in 
recent times, as men gather to discuss matters of concern around the kava 
bowl in villages (Perminow 1993), in town, or in overseas communities 
like Wellington (Tongan resident Tevita Finau, pers comm, 1988), or Mel-
bourne, Australia (researcher Helen Morton Lee, pers comm, 2008). Arne 
Aleksej Perminow found in the course of his extensive fi eldwork in rural 
Tonga (which necessitated drinking kava), that the physiological effects 
from drinking kava among Tongans are not pronounced. Nevertheless, 
Tongans, he contended, have learned to treat kava as if it were strong stuff 
(Perminow 1993). Perminow recorded his informants as saying that kava 
makes people feel wonderfully relaxed, and well disposed toward their 
surroundings, forgetting all their troubles, and becoming “beautifully 
hungry” (1993, 49). Overseas Tongans try to obtain kava from home, but 
may use Fijian kava if it is not available. The Australian ban on kava (dis-
cussed later in this article) has reduced the availability of kava for use at 
informal sessions (Filihia 1998; Meredith Filihia, pers comm, April 2008). 
Although it is no longer available online (Filihia, pers comm, 2008), the 
“Kava Bowl” took on new symbolic meaning in the form of an Internet 
discussion forum for Tongans around the world (Lee 2003, 1).
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Eight cultivars were named when Lebot collected samples in 1987. The 
names refer to the morphological characteristics, particularly the color of 
the stems, and the space between nodes, that is, the internodes (Lebot, Mer-
lin, and Lindstrom 1992). Presentations of the whole root, together with 
stems and leaves (kava toho), are considered the most honorifi c, and thus 
are used for royal kava occasions (as discussed earlier) and the installation 
of priests. Presentation of a debarked rhizome and branch (kava teletele) 
honors a person of high status. Taumafa kava and ‘ilo kava are formal 
drinking sessions for the king and nobles, respectively. A faikava is a social 
event held in a house where individuals bring their own kava roots. A kava 
club is for everyday social drinking (Halavatau and Hoponoa 2002). 
A whole kava plant is an important family presentation, along with 
pigs, at any major celebration. Community representatives display their 
best kava plant at the ceremony, where it can be admired alongside other 
such gifts. At the constitutional celebrations in 1976, some one hundred 
and seventy kava plants were presented to the king, and placed alongside 
and at the ends of the long rows of pigs that stretched half way across the 
local rugby fi eld (author’s fi eld notes, 1976). The kava plant was consid-
ered the guardian of the gifts. 
The kava circle, as it is often labeled, is in fact a U-shaped formation in 
which all participants have their place at one side or the other of the high-
est-ranking participant. He sits at the head of the U, facing the open space 
where the kava bowl and the kava maker (usually female) are located. The 
kava maker is assisted by a number of young men and women, as well 
as the master of ceremonies. After the kava root is pounded and water 
added, the liquid is sieved to remove any fi brous material before being 
served in a half coconut shell by the attendants. It is crucial that the kava 
is presented in the correct order to honor the status of everyone seated 
in the kava circle. Women sit outside the formal circle, observing closely 
to ensure that protocol is carefully followed. Their task is to prepare and 
serve the bounteous food that accompanies any kava ceremony.
The “power of kava” lies in its symbolism, which is most keenly 
observed during rituals and ceremonies where the beverage is shared. 
Respect for kava is paramount, evident in the solemnity surrounding a 
kava circle. But it denotes Tongans coming together, where the bonds of 
solidarity may be enhanced around a shared cultural ethic (see papers in 
Pollock 1995). Nightly faikava draw men around the kava bowl to drink 
several “shells” and discuss matters of importance. A 2001 New Zealand 
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court case involving a Tongan pulled over by the police for “drunk” driv-
ing at 3 am raised questions of the status of kava as a substance. After a 
long working day, and having eaten only an apple, the man had drunk two 
shells of kava in the company of his former classmates from Tupou Col-
lege, to celebrate the beginning of the new millennium. The judge eventu-
ally dismissed the case on the basis that kava was not considered an illegal 
substance in New Zealand (author’s expert witness notes, 2001).
In the last ten years the kava plant has become a lucrative cash crop for 
Tongan farmers. In the 1980s an agricultural census estimated that 15 per-
cent of households had planted kava (Lebot, Merlin, and Lindstrom 1992, 
190). In 2000, the total area of kava plantations in Tonga was estimated at 
of 800 hectares. Since that time, the number of hectares has been increas-
ing by about 20 percent per year (Lebot 2002, 4). By 2001, 2,500 hectares 
were planted in kava yielding an average of 2.36 ton / ha. Selling at t$18 
per kg, the yielded netted some t$12 million for the Tongan economy, 
according to the Tongan agricultural census (Halavatau and Hoponoa 
2002). (In 2001, t$1.00 was the equivalent of us$.50.) Commenting on 
the effect of the 2002 ban on Tongan kava growers, Siosiua Halavatau 
and Taniela Hoponoa estimated that some two hundred households had 
lost income due to the European ban, and wondered whether they could 
make up the shortfall selling locally (2002). 
Overseas Tongans use dried kava that they purchase or obtain from 
relatives who carry it from the islands in plastic packets of 500 grams or 
more. In 2007, an Australian ban placed a limit of 2 kg per person on 
any imports, whether carried in personal baggage or sent by mail (Mercer 
2006; tga 2008).This ban brought strong reaction from Tongans as well 
as Fijians (Filihia, pers comm, 2008).
For Tonga’s strongly agricultural-based economy, kava has thus added 
another crop that has vital export potential. This traditional crop can 
be contrasted with introduced crops, such as pumpkin, which have been 
adopted for their export potential, mainly to the Japanese market. Kava, 
along with taro and other Pacifi c crops that have persisted in island agri-
culture for more than 3,000 years, are more sustainable than the newer 
crops introduced for Western usage (Pollock 2008b).
Tonga’s ties with the European Union enabled pharmaceutical compa-
nies to tap Tonga as an additional source of kava. German pharmaceuti-
cal companies had initially shown interest in the effi cacy of Tongan kava 
in the late nineteenth century, and again in the late twentieth century, 
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although they found its chemical compounds to be less potent than kava 
from Vanuatu (Halavatau and Hoponoa 2002). In 2002 a ready market 
for the plant developed in both Europe and the United States, while a 
lesser market for dried pounded kava root has developed among over-
seas Tongans. Kava is readily sought by overseas communities of Tongans 
in New Zealand, Sydney, Honolulu, and California. Tongans prefer their 
“own” kava to the kind processed in Fiji or Vanuatu.
Production of kava is thus likely to continue along traditional lines 
to meet the high demand for the plant as a symbol of Tongan identity, 
whether in Tonga itself, or among overseas communities. The success of 
exports to the pharmaceutical industry is less assured. Tonga has better 
shipping access than Vanuatu, but quality control will be a major con-
cern. The level of kavalactones in Tongan kava may well be the crucial 
unknown. 
Pohnpei
Pohnpei is a high island in the eastern Federated States of Micronesia 
(FSM). The Pohnpeian term for kava, sakau, is said to be a linguistic indi-
cator of its introduction from a Polynesian source to the south, Te kawa 
(Petersen 1995, 36; Keating 1998); alternatively, the term may suggest 
a direct link with Vanuatu’s kava (Lebot, Merlin, and Lindstrom 1992). 
In Pohnpei, sakau has been used as an honorifi c beverage for the com-
plex chiefl y system. Elizabeth Keating assessed ethnographic practices in 
detail, demonstrating that kava is an integral part of power sharing and 
the marking of social space (1998). Recently it has been democratized 
with the opening of many kava bars throughout the island (Balick and Lee 
2002). Yet as Glenn Petersen has noted, “Kava is always treated with the 
respect due its superior mana” (1995, 49). 
Some 660,000 kg of kava is harvested annually for local use in Pohnpei 
(Merlin 2004, 288). Sakau is increasingly consumed by groups of men 
who gather at any one of the some fi fty kava bars—known as marked—
that are scattered around the island, or at unlicensed kava bars; sakau is 
also available at retail stores (Merlin 2004, 288; see also market reviews 
on the Sakau en Pohnpei Web page). The cost of sakau is usually around 
35 or 40 cents per Styrofoam cup or us$2.00 for a bottle. Men meet in the 
evenings between 6 and 11 pm at one or another of these establishments (a 
list of “places to consume” around the island, with photos, can be found 
on the Web page). The author of the Sakau en Pohnpei Web page warns 
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about the dangers of the water used to make sakau, particularly the kind 
sold in bottles: “Bottle sakau is for local stomachs only.” The quality of 
the sakau drink also varies from bar to bar: “The strongest sakau [on Nett 
Point] was Sekeren variant grown near the tip end [of the point],” as sold 
at Palipoa village; elsewhere three cups gives a mataitai (satisfi ed) feeling. 
Sakau is prepared from the root itself, or from purchased packets of kava, 
known locally as “take out.” 
Drinking sakau is still surrounded by cultural protocols in traditional 
settings (Keating 1998). Drinking is considered a quiet time for partici-
pants, with no singing or spitting; it is deemed impolite to attend sakau 
gatherings and not drink. No alcohol accompanies it, although in the 
1990s beer was offered at bars as a “chaser” (Merlin, pers comm, 2008). 
Kava, Petersen argued, binds together the chiefl y side of island political 
relations with the populist side (1995, 55). The honorifi c role of the plant, 
held over from the past, promotes tranquil social relations. 
Pohnpei exports both frozen pounded roots of kava and liquid extracts, 
which are sent mainly to Guam, Saipan, and Hawai‘i for use by FSM expa-
triates and others. Some 300 –500 hectares were under production in the 
mid-1990s, producing 477,000 kg per year, generating us$3 million per 
annum (Merlin 2004, 288). By 2002, exports were valued at us$241,000, 
almost double the return in 2000 (Hezel and Lightfoot 2005; Lebot 2002, 
5), making sakau the Federated States’ third highest value export crop. 
However, a major environmental concern is emerging with the expan-
sion of kava production. Because both individual farmers and the State 
of Pohnpei need the revenue (Merlin and Raynor 2004), Pohnpeians 
have been growing kava in the foothills on land that is unstable due to 
high rainfall (Merlin and Raynor 2005). Land that was formerly used for 
coconut plantations is also being converted to accommodate this lucra-
tive cash crop. Ecologists are closely monitoring the erosion effects of this 
increasingly intensive agricultural activity, and attempts have been made 
to encourage farmers to grow their sakau plantations on lowland areas, 
which are more stable. 
On neighboring Kosrae, kava, known as sukha (or sekal) was intro-
duced, probably from northern Vanuatu via Tonga. “In former times, 
among the nobility, at any rate, kava was no longer a luxury item, but 
rather an everyday beverage” (Sarfert 1908–1910, quoted in Merlin 1993, 
64). However, its close association with honoring the traditional gods of 
the islands led to its condemnation by the American Board of Commis-
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sioners for Foreign Missions (abcfm), who viewed it as evil. Attempts to 
substitute coconut as the drink of everyday people were only marginally 
successful. Efforts may yet be made to revive the cultivation of sukha, if 
it has suffi cient cash-generating potential. Until then, Kosraeans visiting 
Pohnpei will have to settle for drinking sakau at the bars there.
Pohnpei is thus developing its potential as a production site for sakau 
to supply the northern Pacifi c, from Guam to Hawai‘i. The presence of 
Pohnpeians living outside their home island provides a market for the 
dried material as well as the bottled product (Merlin and Raynor 2004). 
Pohnpeian sakau has also been exported to US pharmaceutical companies 
for processing into health remedies. Thus, during the European ban Pohn-
peian farmers were not as drastically affected by the European kava ban 
as their southern neighbors.
Kava Usage in Other Parts of the Pacifi c 
New Caledonia
Ni-Vanuatu and Wallis and Futuna immigrants to New Caledonia drink 
kava, as well as some New Caledonians living in Noumea (author’s fi eld 
notes, Nov 2008; see Chanteraud 2001 for further discussion). Migrants 
carrying their cultural traditions from their homelands, prepare kava for 
both ritual and secular occasions. Men even celebrate church festivities 
and family gatherings around the kava bowl (author’s fi eld notes, 1992, 
1998). These communities have had a signifi cant infl uence on the estab-
lishment of nakamal around Noumea, as well as the importation of roots 
for sale in the markets in Noumea and beyond, and the sale of 1 and 2 kg 
packets of dried kava root. Demand for the plant grows with the expan-
sion of these immigrant communities.
Kiribati
Kava usage is spreading to nonproducing islands, such as the atolls of 
Kiribati. A recent return fi eld visit by Kazuhiro Kazama to Tabiteuea, one 
of Kiribati’s southern atolls, revealed newly introduced kava drinking 
(Kazama 2006). Known there as nangona (a term clearly derived from 
Fijian yaqona), the beverage began being consumed by male villagers in 
2002 /2003. The men stressed that the kava-drinking sessions were com-
munal, and that the practice transformed interpersonal relations (Kazama 
2006, 87). The Catholic Church offers space for these kava gatherings, 
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and missionaries support the activity as an alternative to consuming alco-
hol, as men usually drink kava before a meal or feast, while single women 
may take one cup. Kazama argued that Kiribati katei (custom) is fl exible, 
thus enabling the easy and rapid acceptance of kava.
The kava, purchased in plastic packets of dried powder, is imported 
from Fiji and Vanuatu through relatives returning from education, train-
ing, or meetings in Fiji, or through Banaban relatives. A major increase in 
imports occurred between 1996, when a total of 3,500 kg was imported, 
and in 2000, when 8,700 kg was imported (Kazama 2006, 91). Importers 
may sell it privately in half-kilogram bags for a$30.00. (In 2006, one Aus-
tralian dollar was the equivalent of approximately us$0.73.) The govern-
ment’s response to requests to regulate the price has led to a rise in import 
duties to prevent excessive consumption. Thus, the price continues to rise 
(Kazama 2006, 92). 
Australian Aborigines
Kava was introduced to Aboriginal communities in the Northern Territory 
in the 1980s as an alternative to alcohol. Imported from Fiji and Vanuatu, 
it has had a checkered history, leading to a ban on imports by the Austra-
lian government in June 2007 (rnzi, July 2007). The concern is that kava 
poses health problems in Aboriginal communities. Since Peter d’Abbs doc-
umented details of the developments in kava policy (1995), such concerns 
have been debated by the churches, Northern Territory authorities, and 
the House of Representatives Standing Committee on Aboriginal Affairs, 
as well as Aboriginal communities themselves. Kava has become a politi-
cal issue for both Northern Territory and national government parties. 
Further, the churches, which fi rst advocated its use, have since changed 
their stance, thus adding to the general confusion regarding the issue (see 
Altman and Hinkson 2007; Mathews and others 2002).
The importation of kava from Fiji and Vanuatu by Australian middle-
men has led to increased prices (d’Abbs 1995). Since 1997, imports have 
been permitted into Australia in accordance with the National Code of 
Kava management. The quantity of kava imported has increased ten fold 
since 2002, leading to the present move by the Therapeutic Goods Admin-
istration (tga) of the Australian government to reinforce existing regula-
tions on kava imports (tga 2005). The ban as activated in 2007 placed a 
limit of 2 kg for any one person, whether traveling or receiving imports of 
kava by mail. The Australian government is being asked to rethink the ban 
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because kava has been proven harmless. Furthermore, Lebot has argued 
that government offi cials should take into account the impact of the ban 
on Vanuatu farmers who have few other sources of income (Lebot 2006; 
rnzi, Aug 2007; see also Altman and Hinkson 2007). 
Summary
The four ethnographic sketches presented here illustrate that sustainability 
of the kava trade is dependent on a variety of practices in kava usage and 
sales, as well as cultivation of selected cultivars. Customary local usage 
is still strongly maintained in all four communities, both for ritual and 
secular occasions, with considerable “democratization” through the inclu-
sion of non-noble men and some women. Supply for this usage is likely to 
continue.
Local usage in kava bars has provided an income source for farmers, 
but is dependent on purchasers’ access to cash to buy a shell (or cup) of 
the beverage at a nakamal or grog shop. As the data for Pohnpei indicate, 
the number of kava bars and outlets is increasing rapidly, so farmers can 
expect and, indeed, encourage the continued expansion of kava use in 
the local context. Nevertheless, local government policies appear to be 
ambivalent about this kind of development.
Communities based in metropolitan countries, as well as in other 
Pacifi c Islands, also continue to use kava for ritual and customary ceremo-
nies. Small amounts remitted by relatives at home must be supplemented 
by purchasing supplies locally from metropolitan stores. This section of 
the trade is likely to grow as those communities continue to expand and 
wish to use kava as a strong medium of cultural identity. But trade is also 
impeded by national policies that categorize kava as a drug—for example, 
Australia’s recent ban on imports of more than 2 kg, which still holds 
despite the lifting of the European ban. Such a restriction does not yet 
apply to Australia’s neighbor, New Zealand, which is home to a large 
population of Pacifi c Islanders, many of whom come from islands where 
kava is consumed.
Pharmaceutical company interests, European and American, appeared 
to offer lucrative outlets for Pacifi c kava farmers during the 1990s. Com-
mercial possibilities explored by German pharmaceutical companies at the 
beginning of the twentieth century were reawakened with the growth in 
the market for natural herbal remedies (Brunton 1989). Trade from Vanu-
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atu and Fiji, which had expanded dramatically in the late 1980s (Lebot 
2006), was cut short by a ban on imports to Europe in 2002, when “kava 
pills” were deemed a health risk. As with many products, the sudden 
cessation of sales had left kava farmers with plantations that no longer 
offered a cash return. The European ban pressured kava traders to unite, 
both to fi ght the ban and to strengthen other outlets for sales of their root-
stock. Support from a wide community of concerned supporters such as 
the Pacifi c Islands Forum, academics, and kava users, led to exploration 
of various avenues to seek the lifting of the kava ban. The formation of 
the International Kava Executive Council provided a signifi cant commu-
nication link between Pacifi c interest and European pharmaceutical trad-
ers (see ikec 2004). Quality controls and standardization of the product 
shipped from the Pacifi c were key factors necessary for the resumption of 
trading (Lebot 2006; ikec 2008). 
The insecurity of market access was a major incentive to get the ban 
lifted. Now that has been achieved, Pacifi c farmers will have to work 
together to grow the particular cultivar that produces the most desirable 
kavalactones, a determination that remains to be made by the European 
pharmaceutical companies. Already farmers on Pentecost Island, Vanuatu, 
are being encouraged to plant one particular cultivar, Borugu, as a variety 
likely to meet the new criteria (Charles Long Wah, pers comm, Oct 2008). 
However, whether other Pacifi c community farmers agree to grow a single 
type of cultivar remains to be seen. In Europe, research chemists and oth-
ers continue to work toward consensus regarding the type of kavalactone 
signature to be encapsulated in kava pills in the future.
Other outlets remain to be explored. Several Web sites aimed at visitors 
to Tonga, Hawai‘i, and Vanuatu, promote “the kava experience” to tour-
ists (see, for example, http://www.vanuatutourism.com/vanuatu/cms/en/
activities/kava.html). Bottling kava as a drink has not yet been successful. 
The possibilities of marketing to Asia and Africa remain open. Emphasis 
on kava as an herbal remedy rather than a drug is necessary to avoid the 
stringent drug laws of metropolitan countries. 
Not only did the European ban prove to be a major setback for kava 
farmers’ export trade, but internal wrangling between the major island 
producers must also be resolved. Producers and their trading agents in 
Vanuatu and Fiji must iron out inconsistencies in sales prices (Narsey 
2004, 52). Charges that Vanuatu dealers were “dumping” Vanuatu kava 
in Fiji for f$11–12 per kg, below Fiji’s price of f$21–22 per kg, led Fijian 
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farmers to fear that their crops would not sell. In response, they asked 
the Fiji Kava Council to impose a ban on imports of kava from Vanuatu. 
In addition, the Fiji Kava Council raised fears that “Tu Dei” kava from 
Vanuatu was too strong by Fijian standards, such that Fiji’s “working 
class” was at risk of getting sick (see Aporosa 2006 for further details). 
But as Wadan Narsey observed (2004, 52), “Fijian kava drinkers tend 
not to differentiate kava as long as it is kava,” so they buy at the “best” 
price. Narsey argued that the kava case raises issues of fair trade between 
large and small nations within the Pacifi c based on criteria such as health, 
employment, and other factors that discourage competition. These have 
come to the fore as many aspects of the European ban were being debated, 
and will be exacerbated as “the road map” seeks to establish a standard-
ized cultivar.
The Secretariat of the Pacifi c Community (spc) has also contributed 
to the debate about the health risks of kava drinking, as asserted by the 
European pharmaceutical companies (PIN 2005). The secretariat advised 
its readership that since evidence regarding possible side effects of kava 
consumption within the Pacifi c is limited, Pacifi c communities should 
consume kava with moderation and that those few women who drink it 
should avoid kava during pregnancy and lactation. They suggested more 
research was necessary, and were awaiting the fi ndings of the World Health 
Organization (who) report (PIN 2005). It is too early to assess effects of 
the lifting of the ban, or how the who recommendations will impact on 
the kava trade, production of kava products, and consumption patterns 
around the world.
Categorization of kava as a drug has long been debated (see, eg, Lebot, 
Merlin, and Lindstrom 1992; see Pollock 2001 and Pollock forthcoming 
for a summary of arguments). Western partakers refer to the plant’s mind-
altering effects, particularly in relation to Vanuatu kava. However, local 
analyses stress its social strengths and its quiescent pacifying qualities in 
contrast to alcohol. Its local uses as a medicine have been underreported, 
and thus are poorly understood. 
Inclusion of kava within Western “drug” protocols is having serious 
repercussions for the sustainability of the kava trade. Bans such as the one 
in Australia will reduce the amount of kava exported from Vanuatu and 
Fiji. Availability for customary practices such as Tongan faikava may be 
restricted, although packets of kava can still be obtained through personal 
contacts (Filihia, pers comm, Dec 2008). Further, the reputation of kava 
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is damaged by association with illegal drugs; concerns about the use and 
trading of cannabis by kava users resulted in a major police raid of naka-
mal around Noumea in October 2008 (Les Nouvelles New Caledonia, 
1 Nov 2008). 
Bans Imposed by the German Pharmaceutical Industry 
The lifting of the ban on imports of kava material to Europe in Octo-
ber 2008 has been strongly welcomed in the Pacifi c. In 2002 the German 
Federal Institute of Drugs and Medical Devices (BfArM) had imposed a 
ban on the sale of kava pills as herbal medicines, a measure that was fol-
lowed by a number of other European countries. Rescinding the ban was 
due in large part to a World Health Organization report that examined 
extensive reports on the cases of liver damage, which indicated that the 
hepatotoxicity issues were not as serious as was fi rst claimed (who 2007). 
The BfArM claim, based on 39 initial case reports (tmec 2002), led other 
producers to voluntarily recall their products. Switzerland, France, and 
later the United Kingdom and Brazil also instituted a ban on the sale of 
kava pills (for details, see Pollock forthcoming). Sales of kava roots from 
the Pacifi c ceased. According to the International Kava Executive Council, 
“a traditional drink from the Pacifi c spontaneously mutated from a safe 
and effective drug into a highly dangerous substance” (ikec 2004).
Specialists in herbal medicine, pharmacology, toxicology, as well as other 
health researchers examined in detail the cases of hepatotoxicity cited by 
the BfArM (see Schmidt 2007 for an overview). Reports that the BfArM 
had omitted many facts, such as patients’ existing liver damage and alcohol 
use, and the small number (less than a hundred) of adverse health events 
in proportion to millions of pills consumed suggests that many of the cases 
could not be directly related to the intake of kava pills. The Traditional 
Medicines Evaluation Committee (tmec), a subcommittee of the European 
Herbal Practitioners Association, argued that from their reexamination of 
BfArM’s thirty cases these toxicity claims needed reconsideration, since 
the synthetic kavains (type of kavalactone) extracted by pharmaceutical 
companies were “manufactured into concentrated products made from 
acetone extracts and high alcohol concentrates” (tmec 2002). These latter 
processing elements, rather than the kavains themselves, may be triggers 
of liver damage in some cases. The authors of the tmec report recom-
mended that those with existing liver damage not use kava pills.
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On behalf of the Pacifi c Islands Forum Secretariat (pifs) and some kava-
producing countries, the Center for Development Enterprise, a European 
Union institution, together with the European Scientifi c Cooperative on 
Phytotherapy, commissioned Phytopharm Consulting to critically evaluate 
the justifi cation for restrictions placed on kava by some European health 
authorities. Their report in March 2003 underlined the safety and effi cacy 
of kava and confi rmed scientists’ views that the kava ban was unjustifi ed. 
Scientifi c data had been ignored or misinterpreted, they claimed (Gruen-
wald and Mueller 2003; ikec 2004). 
In the Pacifi c, a conference convened in 2002 in Suva under the aus-
pices of the Pacifi c Islands Forum Secretariat led to the formation of the 
International Kava Executive Council in 2004 under the chairmanship of 
Dr Joerg Gruenwald (Finau and others 2002; ikec 2004). Representatives 
of Pacifi c Islands Forum nations, kava trading stakeholders, and research-
ers met with European pharmaceutical representatives to discuss ways in 
which the ban could be overcome. They concluded that the risks associ-
ated with kava pills were overstated, but recognized the need to establish 
quality controls and standards for the export of kava roots and continued 
dialogue if the ban was to be lifted. The World Health Organization was 
asked to provide an independent overview of the health risks of kava; that 
report was made public in August 2007 (who 2007).
In 2006, the United Kingdom upheld the ban imposed by Germany, 
France, and Switzerland (see Richardson and Henderson 2007 for a sum-
mary of the safety issues associated with kava from a regulatory perspec-
tive). Meanwhile, France agreed to commission research into ways the 
kava product exported from Pacifi c countries could be standardized to 
meet pharmaceutical manufacturers’ specifi cations (Lebot 2006). 
Mathias Schmidt’s summary of “Quality Criteria for Kava,” from the 
perspective of a pharmacist, uses “kavalactone signatures” to underline 
the differences between kava cultivars for defi ning kava quality (2007, 
45). While Schmidt noted that despite numerous pharmacological and 
toxicological studies, “no convincing proof of an inherent toxicity of kava 
exists” (2007, 44), he advised that quality specifi cations should encompass 
several factors: no use of peelings or chips from the aerial parts of kava 
stumps; the need for a system to trace the origin of the roots exported; the 
use of “noble” cultivars with high kavain content; and use of healthy and 
fully matured plants of a minimum of three years old (2007, 46–47).
The 2007 who report, titled “Assessment of the Risk of Hepatotoxic-
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ity with Kava Products,” distinguishes between water extracts of kava 
(ie, traditional kava preparations, or “teas”) and the organic extracts 
(ethanolic and acetonic) and synthetic products as used in European and 
North American preparations of pills or capsules (who Executive Sum-
mary 2007, 2). The authors found no hepatotoxicity in clinical trials, nor 
did experimental studies show kava to have a toxic effect on the liver; no 
epidemiological studies have been conducted. Their examination of 93 
case reports found 53 cases of possible association, but insuffi cient data 
to confi rm, and 8 cases of probable association with liver problems from 
which patients recovered on withdrawal of kava; 14 patients had liver 
transplants, and 8 had died. They concluded that kava products have a 
strong propensity for kava /drug interactions when patients use organic 
extracts, or have heavy alcohol intake, preexisting liver damage, some 
genetic polymorphisms, or excessive dosage and co-medication with drugs 
that may affect the liver. Kava alone does not cause liver damage but in a 
very few cases may exacerbate toxic symptoms (Executive Summary, who 
2007).
The way forward is thus to establish measures of quality control that 
are agreed between European pill manufacturers and Pacifi c traders. Stan-
dardizing the kava material exported so that levels of kavalactones can be 
predicted, eliminating the stem and other by-products of the kava roots 
themselves, and clearly indicating the provenance of root material are vital 
to quality assurance (Ernst 2007). These are the baseline steps in a “2 year 
road map” for moving forward to pursue the necessary legal, scientifi c, 
and “institutional strengthening and organisational establishment to man-
age and drive these processes and strategies” (ikec 2008, 2). When this 
process is accomplished, sales of kava root material will recommence, and 
kava pills will become available again in European health stores.
Ban on Kava Imposed by Australian Government
As mentioned earlier, in June 2007 the Australian government banned 
the importation of kava powder in bulk, and placed a limit on personal 
imports to one 2 kg packet per person (rnzi, June 2007). This move was 
designed to limit the access by Aborigines, particularly those living in the 
Northern Territory, to the kava introduced twenty years earlier as an alter-
native to beer and alcohol (d’Abbs 1995; Alexander, Watson, and Fleming 
1987).
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The effect of this ban on kava imports to Australia has yet to be assessed. 
Some commentators include it as another example of “racism,” while 
 others draw attention to its effects on those Pacifi c Island communities 
that use kava (often purchased) for their national rituals. It is too early to 
gather any assessment of the effects of this ban, either on Australian com-
munities, or the island exporters. 
Is Kava a Drug?
The categorization of kava is raising concerns that could lead to further 
bans. In the Pacifi c the term kava is used for both the plant and the rituals 
during which it is drunk, diluted with water; the World Health Organiza-
tion refers to this water extract as a “tea” (who 2007). Casual users from 
outside the Pacifi c, as well as analysts of the effects (eg, Lebot, Merlin, and 
Lindstrom 1992), have used the “drug” label to refer to the pharmaco-
logical properties and its effects. Others have provided various labels such 
as herbal remedy, natural medicine, dietary supplement, nutraceutical, or 
anxiolytic (see, eg, Cupp 1999; Schmidt 2007; Ernst 2007). Their con-
cerns have focused on the mind-altering properties of the kava beverage, 
as headlined in Kava: The Pacifi c Drug (Lebot, Merlin, and Lindstrom 
1992; republished under the title Kava: The Pacifi c Elixir in 1997). In 
contrast, the Binihi and Jowitt survey found that among ni-Vanuatu, kava 
drunk in the company of other men was “socially addictive,” rather than 
psychologically addictive (McDonald and Jowitt 2000). 
The kava beverage in its diluted form produces a soporifi c effect, in 
contrast to alcohol’s intoxicating effect. The addictive qualities of kava 
are similar, I suggest, to those associated with drinking tea, coffee, cocoa, 
and other beverages. Consistent with this, the who label “tea” appears to 
locate kava outside the strong drug category.
A second question arises whether kava should appear on lists of pro-
hibited drugs, for example, on New Zealand’s Land Transport Act 1998. 
Kava is not included in the US Food and Drug Administration rules (Reeder 
and Cupp 2000), but an arrest in California in 2001, and three arrests in 
New Zealand have raised the issue of this classifi cation. In the fi rst New 
Zealand case, mentioned earlier, the Tongan arrested for a drunk-driv-
ing offense after he had drunk two shells of kava had his case dismissed 
because, we argued, kava was not a prohibited substance in New Zealand 
(author’s case notes, 2001). Two other arrests for drunk-driving offenses 
after drinking kava, one in Palmerston North and one in Nelson (both 
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in July 2007), resulted in those men being banned from driving for nine 
months (Aporosa, pers comm, 2007). The “drug” charge seems to be 
related to how each judge assesses kava. “Kava is not currently classifi ed 
under the New Zealand Misuse of Drugs Act and there are no plans to 
reconsider its status at this time” according to an e-mail message sent to 
me from the New Zealand National Drug Policy Team (25 March 2008). 
The contrast between kava used as a beverage and the pills sold as 
herbal remedies to reduce anxiety and promote sleep is very marked (Pol-
lock 2001). Many generations of Pacifi c Islands peoples have developed 
their own cultural tastes for kava drinks, while Europeans have discov-
ered kava pills as natural medicines only very recently. It remains unclear 
whether these “over the counter psychotropics” (as Helligenstein and 
Guenther refer to them [1999]) should be included under the drug label.
The question of the drug classifi cation is likely to restrict sustainability 
of the kava trade, whether for use as a beverage or as a pill. Governments 
have the power to ban substances they deem to be harmful to health, and 
the power of pharmaceutical companies to infl uence the use of substances 
such as kava as “health remedies” is legendary, as Shiva (1995) and Stig-
litz (2006) have argued. Growth in the demand for alternative medicines 
has appeared to offer lucrative returns to Pacifi c farmers as well as to the 
pharmaceutical manufacturers. But categorization of kava as a “drug” is 
also likely to raise prohibitions against its sale on worldwide markets. 
Conclusions
The lifting of the kava ban as announced by the International Kava Execu-
tive Council in October 2008 is welcome news for Pacifi c farmers. The 
kava trade can be sustained for both current and future generations of 
farmers and drinkers, depending on how the alternatives discussed above 
pan out. Customary usage and trade continue to draw on farmers’ pro-
ductions in Vanuatu, Fiji, Tonga, and Pohnpei, thereby upholding impor-
tant cultural practices and also yielding a cash return. Opportunities exist 
for expansion in alternative markets but obstacles still exist such as the 
drug label ascribed to kava, as well as environmental concerns in Pohnpei. 
Kava falls within the call for the World Trade Organization’s “free mar-
ket trade rules [to] be replaced by a General Agreement for Sustainable 
Trade, making protection and diversifi cation of national economies the 
rationale for world trade” (Shiva and Hines 2006, 56). Regional coopera-
tion between Pacifi c and European interests by means of the International 
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Kava Executive Council has already established valuable dialogue and rec-
ommendations for standardizing the kava product. These links are vital to 
meet both internal directions and external demands on the kava trade.
The ban on exports of kava to European pharmaceutical companies 
created major setbacks for farmers and national economies in the Pacifi c, 
and thus weakened trust in this export link. Now that the ban has been 
lifted, further research is needed as to the steps necessary to market a more 
standardized product with a known kavalactone signature, or to fi nd alter-
natives to the ethanol and acetone used in pharmaceutical production of 
the pills, as the 2007 who report recommends. Standardization is a major 
step necessary to establish the quality of kava exported, but will run coun-
ter to the biodiversity of Pacifi c knowledge and practices developed over 
the past 3,000 years (Pollock 2008a). Alternative export avenues using 
different extractive techniques, and targeting other markets such as Asia, 
also await development. Kava-producing nations have the choice of sev-
eral options, each with cultural signifi cance and varying returns. 
The future of the kava trade depends on keeping open as many options 
as possible. Kava as a Pacifi c icon is already widely recognized beyond 
its Pacifi c cultural setting. Variation in tastes for the kava brew sustain 
its biodiversity by way of a number of alternative modes of consump-
tion, from fresh root, to dried root, kava powder or pill. Such variation 
is essential to the sustainability of kava production and the kava trade in 
and beyond the Pacifi c. 
* * *
I am grateful for the comments and recommendations made by several review-
ers on two drafts of this paper. These suggestions have been incorporated in this 
fi nal paper. 
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Abstract
Sustainability of trade in kava, which was severely compromised by a 2002 ban 
on exports from Pacifi c Islands to European pharmaceutical companies, has 
reached a new phase. Exporters vigorously fought the ban, imposed as a result of 
claims that kava pills, sold as herbal remedies for reducing anxiety, sleeplessness, 
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and depression, were toxic to the liver of individuals who took them. Concerted 
reaction by Pacifi c interests such as the Pacifi c Islands Forum Secretariat led to the 
formation of the International Kava Executive Committee, which sought ways to 
get the ban lifted. A 2007 World Health Organization report found that the pro-
cess of manufacturing the pills was more likely to be toxic to some pill takers than 
the kavalactones drunk in traditional beverages; quality control and changing the 
manufacturing process could allow exports of kava to Europe to resume.
Meanwhile, alternative outlets for sales of kava have been growing, which 
may help to sustain the kava trade and provide an income for farmers. Expanding 
Pacifi c Islander communities in Australia, New Zealand, and the United States 
are using kava to maintain identity ties to their homelands, such as Vanuatu, 
Fiji, Tonga, and Pohnpei. In parallel, sales of kava within local communities are 
increasing through markets, nakamal, and kava cafes, and Web sites promote the 
product. These tracks for sustaining kava trade will need further development 
throughout the Pacifi c region, and beyond.
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